ADVERTISEMENT

M & A

Gateway To Africa: Natco Bids For 35.75% Of Adcock Ingram

Natco to buy out Adcock Ingram’s minority shareholders in what’s possibly its biggest M&A investment, opening up substantial opportunities in South Africa and the region. If the offer goes through, it will result in the delisting of Adcock, with Bidvest and Natco co-owning the firm.

Irish Ruling Gives Go-Ahead For Endo-Mallinckrodt Merger

A ruling from Ireland’s High Court has cleared the way for Endo and Mallinckrodt to consummate their merger in early August.

Sanofi Doubles Down On Respiratory Vaccines With Vicebio Buy

The French major is paying $1.15bn For the UK biotech and its bivalent candidate, VXB-241.

Adalvo Changes Hands As EQT Takes Control

Private equity firm EQT is taking control of Alvo group B2B business Adalvo, after striking a deal to acquire a majority stake from Aztiq, the investment vehicle of founder Róbert Wessman.

Geopolitical Volatility Not Dimming A Healthy Mid-Term Outlook For Life Sciences Deals

New report by global law firm Taylor Wessing and Bayes Business School forecasts a steadily increasing volume of major life sciences M&A in the coming five years, but highlights concerns over cybersecurity and unrealistic valuations. Taylor Wessing partner Andrew Edge spoke to In Vivo.

Sino Biopharm Scoops LaNova In Chinese Pharma’s Biggest Biotech Buyout So Far

Sino Biopharm will pay almost $1bn to acquire what target LaNova’s CEO described as an “exploding” pipeline, which includes six clinical-stage candidates in the oncology area.

Kenvue Makes CEO Change Months After Critical Activist Investor Made Proxy Play For Board Seat

Thibaut Mongon is out as Kenvue CEO, a post he’s held since J&J spun it out in July 2023, after the firm’s results came under increased investor scrutiny over the past year. The board appointed as interim CEO Kirk Perry, a board member since December who most recently headed technology, data and pre

Deals In Depth: June 2025

Five $1bn+ alliances were penned in June, and four exceeded $2bn.

Deals Shaping The Medtech And Diagnostics Industries, June 2025

An interactive look at medtech and diagnostics deals made during June 2025. Data courtesy of Biomedtracker.

Alvotech Boosts Packaging Abilities With Ivers-Lee Acquisition

Alvotech has acquired long-time partner Ivers-Lee to expand its in-house capacity for assembly and packaging ahead of key planned biosimilar launches in 2025, strengthening operational control and supporting global growth.

BREAKING NEWS: Merck & Co. Leaps Into COPD Space With $10bn Verona Buy

The UK firm's chronic obstructive pulmonary drug Ohtuvayre has been enjoying a stellar launch.

Concentra Picks Up Cargo In Latest Troubled Biotech Buyout

The Kevin Tang-led firm will pay $4.38 per share for Cargo, which laid off most of its workforce following the failure of a Phase II CAR-T trial.